View Author

Abraham Tanis, A.

( A. Abraham Tanis)


mycophenolate mofetil transplantation coliti mycophenolate mofetil patient cmv disease colon cmv colitis vasculiti transplant cytomegaloviru disease blood ischaemic colitis cmv vasculitis study cmv inclusion bodies biopsy rejection therapy fever department infection colon biopsies medicine i submucosal haemorrhage ischemic colitis antibody production group prevention ischaemic diagnosis h &e fig transplantation 1 month 3. colon biopsy university hospital rotterdamdijkzigt ganciclovir tissue figure ischemic colitis introduction ischemic examination complication submucosal inclusion pp 65 titer blood cells 509/1 transplantation study group university hospital rotterdam-dijkzigt medicine oedema submucosal blood vessels tricontinental mycophenolate mofetil cadaveric 2. colon biopsy doppler ultrasound endoscopic image control groups wasserman pb cytomegalovirus colitis stool cultures placebo-controlled study induction therapy cmv studies toxin assays venous thrombosis cmv reactivation medicine ii serum creatinine cmvseropositive patient sigmoid colon laboratory correspondence cmv seropositive curr opin cytomegalovirus infection torensma r patchy vasculitis transplant recipients drug regimens




1 Most Recent Publications

Cytomegalovirus colitis in a CMV-seropositive renal transplant recipient on triple drug therapy (including mycophenolate) (Article)
Smak Gregoor, P.J.H. Gelder, T. van Abraham Tanis, A. Chadha-Ajwani, S. Klaassen, R.J. Weimar, W.
1997-01-01